February 3rd, 2023
•This study developed a noninvasive and real-time method to evaluate the distribution of programmed death-ligand 1 in the whole body, based on positron emission tomographic imaging of [68Ga] D-dodecapeptide antagonist. This technique has advantages over conventional immunohistochemistry and improves the efficiency of identifying appropriate patients who will benefit from immune checkpoint blockade therapy.
Tags
Related Videos
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Protocol for HER2 FISH Using a Non-cross-linking, Formalin-free Tissue Fixative to Combine Advantages of Cryo-preservation and Formalin Fixation
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts
Development and Angiographic Use of the Rabbit VX2 Model for Liver Cancer
A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Copyright © 2024 MyJoVE Corporation. 판권 소유